Dangond F and Gullans SR |
Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9647779
|
Takamatsu G et al. |
Tescalcin is a potential target of class I histone deacetylase inhibitors in neurons. |
2017 |
Biochem. Biophys. Res. Commun. |
pmid:27939885
|
Choy SW et al. |
C. elegans SIN-3 and its associated HDAC corepressor complex act as mediators of male sensory ray development. |
2007 |
Biochem. Biophys. Res. Commun. |
pmid:17506990
|
Cowell RM et al. |
Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells. |
2009 |
Biochem. Biophys. Res. Commun. |
pmid:19118529
|
Zampetaki A et al. |
TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. |
2006 |
Biochem. Biophys. Res. Commun. |
pmid:16814255
|
Wu P et al. |
Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:16051188
|
Yamamura A et al. |
Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. |
2013 |
Biochem. Biophys. Res. Commun. |
pmid:24134849
|
Rao J et al. |
Trichostatin-A induces differential changes in histone protein dynamics and expression in HeLa cells. |
2007 |
Biochem. Biophys. Res. Commun. |
pmid:17869223
|
Herr MJ et al. |
Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activity. |
2014 |
Biochem. Biophys. Res. Commun. |
pmid:24747564
|
Lopatina NG et al. |
Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:12810068
|
Hasegawa T et al. |
Cloning of a GADD34-like gene that interacts with the zinc-finger transcription factor which binds to the p21(WAF) promoter. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10066455
|
Inokoshi J et al. |
Neuronal differentiation of neuro 2a cells by inhibitors of cell cycle progression, trichostatin A and butyrolactone I. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10079191
|
Bai J et al. |
Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. |
2006 |
Biochem. Biophys. Res. Commun. |
pmid:16904634
|
Liu J and Li Y |
Trichostatin A and Tamoxifen inhibit breast cancer cell growth by miR-204 and ERα reducing AKT/mTOR pathway. |
2015 |
Biochem. Biophys. Res. Commun. |
pmid:26436206
|
Hara D et al. |
Persistent BDNF exon I-IX mRNA expression following the withdrawal of neuronal activity in neurons. |
2009 |
Biochem. Biophys. Res. Commun. |
pmid:19818730
|
Tan HH and Porter AG |
p21(WAF1) negatively regulates DNMT1 expression in mammalian cells. |
2009 |
Biochem. Biophys. Res. Commun. |
pmid:19275888
|
Lattal KM et al. |
Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. |
2007 |
Behav. Neurosci. |
pmid:17907845
|
Miyagawa K et al. |
Possible involvement of histone acetylation in the development of emotional resistance to stress stimuli in mice. |
2012 |
Behav. Brain Res. |
pmid:22963996
|
Moldrich RX et al. |
Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. |
2013 |
Behav. Brain Res. |
pmid:24103642
|
Knobloch J et al. |
Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease. |
2014 |
Basic Clin. Pharmacol. Toxicol. |
pmid:23981542
|
Li J et al. |
Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. |
2010 |
Autophagy |
pmid:20543569
|
Liu YL et al. |
Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. |
2010 |
Autophagy |
pmid:20962572
|
Bao Y et al. |
Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells. |
2009 |
Atherosclerosis |
pmid:18930459
|
Sanaei M et al. |
Genistein and Trichostatin A Induction of Estrogen Receptor Alpha Gene Expression, Apoptosis and Cell Growth Inhibition in Hepatocellular Carcinoma HepG 2 Cells |
2017 |
Asian Pac. J. Cancer Prev. |
pmid:29286617
|
Shi QQ et al. |
Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling. |
2014 |
Asian Pac. J. Cancer Prev. |
pmid:25292076
|
Zohre S et al. |
Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer. |
2014 |
Asian Pac. J. Cancer Prev. |
pmid:25169491
|
Yang XL et al. |
Effect of trichostatin A on CNE2 nasopharyngeal carcinoma cells--genome-wide DNA methylation alteration. |
2014 |
Asian Pac. J. Cancer Prev. |
pmid:24969901
|
Cheng DD et al. |
Antitumor activity of histone deacetylase inhibitor trichostatin A in osteosarcoma cells. |
2012 |
Asian Pac. J. Cancer Prev. |
pmid:22799338
|
Zhang QC et al. |
Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line. |
2012 |
Asian Pac. J. Cancer Prev. |
pmid:22994780
|
Gillespie J et al. |
Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. |
2012 |
Arthritis Rheum. |
pmid:21952924
|
Farrajota K et al. |
Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. |
2005 |
Arthritis Rheum. |
pmid:15641079
|
Culley KL et al. |
Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. |
2013 |
Arthritis Rheum. |
pmid:23575963
|
Wang Y et al. |
Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. |
2006 |
Arthritis Rheum. |
pmid:16802366
|
Huber LC et al. |
Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. |
2007 |
Arthritis Rheum. |
pmid:17665426
|
Hemmatazad H et al. |
Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. |
2009 |
Arthritis Rheum. |
pmid:19404935
|
Cai D et al. |
Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis. |
2015 |
Arthritis Res. Ther. |
pmid:26408027
|
Misaki K et al. |
Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice. |
2011 |
Arthritis Res. Ther. |
pmid:21592365
|
Dje N'Guessan P et al. |
Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19122173
|
Choi JH et al. |
Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16141407
|
Inoue K et al. |
Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. |
2006 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17008592
|
Colussi C et al. |
P300/CBP associated factor regulates nitroglycerin-dependent arterial relaxation by N(ε)-lysine acetylation of contractile proteins. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:22859492
|
Nordén R et al. |
Inhibition of protein deacetylation augments herpes simplex virus type 1-activated transcription of host fucosyltransferase genes associated with virus-induced sLex expression. |
2010 |
Arch. Virol. |
pmid:20039087
|
Shinde V et al. |
Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Tox and STOP-Tox tests. |
2017 |
Arch. Toxicol. |
pmid:27188386
|
Pallocca G et al. |
Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. |
2016 |
Arch. Toxicol. |
pmid:26705709
|
Rempel E et al. |
A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. |
2015 |
Arch. Toxicol. |
pmid:26272509
|
Balmer NV et al. |
From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. |
2014 |
Arch. Toxicol. |
pmid:24935251
|
Zapletal O et al. |
Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models. |
2017 |
Arch. Toxicol. |
pmid:27830268
|
Cipriano M et al. |
The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells. |
2017 |
Arch. Toxicol. |
pmid:27909741
|
Lu MC et al. |
Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. |
2009 |
Arch. Toxicol. |
pmid:18709356
|
Min KN et al. |
Estrogen receptor enhances the antiproliferative effects of trichostatin A and HC-toxin in human breast cancer cells. |
2004 |
Arch. Pharm. Res. |
pmid:15202563
|